Take away key perspectives and guidance in the following areas:

Join us for Vaccines: Is the Boom Sustainable during the Obama Era? on Thursday, Jan. 29, 2009 at 12 p.m. EST (9 a.m. Pacific). Listen as our experts help you understand the future before it's begun. Grab your team, a phone and a computer with Web access (that last one's optional). No travel required!

SPEAKERS

	CHRIS COLWELL is a senior advisor in the Washington, DC office of McKenna Long & Aldridge.  He focuses on life sciences and public health preparedness. Prior to joining MLA, Mr. Colwell served as the Director of Healthcare Regulatory Affairs at the Biotechnology Industry Organization (BIO). While there, he directed policy issues related to biodefense/emerging diseases, vaccines, diagnostics, and personalized medicine. Mr. Colwell worked in the FDA's Office of the Commissioner in the Office of Counterterrorism Policy and Planning (OCTPP), where his duties included acting as liaison to Department of Health and Human Services.  He also worked with former Congressman James Greenwood, where he focused on internet pharmacy regulation issues, and at PhRMA, the Pharmaceutical Research and Manufacturers of America in Washington, DC. Before focusing his career on policy matters, Mr. Colwell worked in the vaccine division of Merck and Co. Inc., where his final position was Area Head of Bacterial Vaccine Manufacturing. His responsibilities at Merck included vaccine facility design, construction and validation; process scale-up; and management of on-going manufacturing processes, including regulatory affairs. Mr. Colwell received his Masters in Public Policy from Georgetown University. He did his undergraduate studies at Pennsylvania State University, earning a B. S. in chemical engineering.
	DACK DALRYMPLE is Principle & consultant of Dalrymple & Associates for civilian and biodefense vaccines and other medical countermeasures. Prior to founding Dalrymple Associates, Mr. Dalrymple was Director of Medical Government Relations, American Cyanamid Company, Lederle Laboratories from 1979 to 1996. From 1973 to 1979, he served as Legislative Assistant & Counsel to Rep. Paul G. Rogers (D-FL), Chairman of Subcommittee on Health, US House of Representatives, for NIH, FDA, CDC, biological, drug, medical device and other health care-related initiatives. Mr. Dalrymple earned a BA in Government in 1969 and his JD in Law in 1973.
	ISABELLE CLAXTON has more than 25 years of experience in global health care policy and communications.  She currently is head of public policy & advocacy for the GlaxoSmithKline Vaccine Division. Before joining GSK, she was executive vice president at the PR firm of  Porter Novelli, where she managed three award-winning pharmaceutical teams. Ms. Claxton was vice president for communications at the International AIDS Vaccine Initiative, working on programs in Africa and India and served as a consultant to WHO on HIV/AIDS vaccine development.  She spent 10 years at Merck as Executive Director for Strategic Communications, beginning as a lobbyist in the company's Washington, DC, office and managing public affairs initiatives for the Merck Vaccine Division. Prior to Merck, she worked on Capitol Hill as Director of Communications for the Senate Special Committee on Aging and as Deputy Chief of Staff  for the late Sen. John Heinz (R-PA). Ms. Claxton has also served as editor-in-chief for several health-related publications and as a writer for BusinessWeek. She holds a Masters Degree in U.S. Constitutional History from the University of Virginia.

BENEFITS

What does registration get me?

• One (1) phone line, for you alone, or around which to gather your team(s). Toll-free in the U.S. only.
• One (1) password to a website on which you'll be taken through the presenters' slides as they speak to them.
• An interactive Q&A round with speakers: Type your questions on the website during the presentation, for the speakers to address afterward.
• Online access to the audio and slides of the entire event if you can't attend the webinar live, and still want to hear the content.
• The insight you've come to expect and respect from Elsevier Business Intelligence, FDC Reports and Windhover and our guest speakers.

• Convenience – and lower cost. Your entire team can listen in one room. No travel required!
• A team approach. You've often wanted to have everyone on your team getting the same knowledge and insight you derive from physical conferences. Now you can.
• Interactivity. You're remote, but not removed. Our webinars let you ask the important, burning, controversial questions of our speakers that you'd be able to pose at a physical conference.
• Flexibility. Want to be able to review what you learn? No problem ... just register for the live webinar PLUS a digital copy of the entire event to listen to at your convenience. Interested in the topic but have a scheduling conflict? Don't worry — the recording is available for purchase at any time!

REGISTER

Register for the live webinar, the live webinar PLUS the audio recording or the audio recording only!

Live webinar: $399
Live webinar plus complete audio recording: $499
Audio recording only: $499

____________________________________________________________

Elsevier Business Intelligence
P.O. Box 7247
Philadelphia, PA 19101-9257
* Tel: +1 (800) 332-2181
* Fax: +1 (908) 547-2165